Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Dividends payables: 2016

Historic Dividends payables for Altimmune (ALT) over the last 1 years, with Dec 2016 value amounting to $197.1 million.

  • Altimmune's Dividends payables was N/A to $197.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $197.1 million, marking a year-over-year change of. This contributed to the annual value of $197.1 million for FY2016, which is N/A change from last year.
  • According to the latest figures from FY2016, Altimmune's Dividends payables is $197.1 million.
  • In the past 5 years, Altimmune's Dividends payables ranged from a high of $197.1 million in FY2016 and a low of $197.1 million during FY2016.
  • For the 1-year period, Altimmune's Dividends payables averaged around $197.1 million, with its median value being $197.1 million (2016).